|
Prostate conditions often cause problems with urination or bladder control. These may include the following:
|
A person should see their doctor if they notice any of the following symptoms Trusted Source:
|
Illustration of stages of Prostate Cancer
|
Unfortunately, most men will develop a prostate problem at some point in their lives. Prostatitis, BPH, and cancer are the three most common causes of prostate problems. Prostatitis is defined as an inflamed prostate. Acute prostatitis and chronic prostatitis are the two main types. Acute prostatitis is caused by a bacterial infection and results in the sudden onset of painful urination, a small stream, and frequently fever and chills. Chronic prostatitis, also known as chronic pelvic pain syndrome, is a more nebulous condition. Its symptoms include persistent or recurring pelvic pain, urination pain or burning, an increased urge to urinate, difficulty emptying their bladders, and/or painful ejaculation. After skin cancer, prostate cancer is the most common type of cancer in men. It affects approximately 1 in every 8 males during their lifetime. The average age of diagnosis for prostate cancer is 66. People can choose whether to have a prostate cancer screening based on their age and risk factors, but they should be aware of the risks of testing ahead of time. |
Type of prostate exams |
Explanation |
Digital rectal examination |
During this exam, the doctor inserts a finger into the rectum and feels the prostate to detect lumps, nodules, and signs of cancer. |
Prostate-specific antigen (PSA) |
Blood tests can assess the levels of this PSA. High levels indicate an increased risk of prostate cancer. |
Prostate biopsy |
If a doctor suspects cancer, they can take a small sample of prostate tissue for testing. To do this, they insert a needle into the prostate via the rectum. |
Prostate ultrasound |
Doctors may refer to this as a transrectal ultrasound. During the procedure, the medical professional inserts a probe into the rectum, positioning it close to the prostate. Doctors usually carry out biopsies with guidance from an ultrasound. |
Prostate MRI |
This can show prostate anatomy in great detail, including identifying areas suspicious for cancer. New technology allows targeting of these areas through an MRI-ultrasound fusion biopsy. |
Scitron is a Mesenchymal Stem Cells (MSCs), derived from human umbilical cords. Upon treatment, the cultured cells are injected intramuscularly / intravenously into the patient. The cells are characterized by low immunogenicity. Hence, it is very safe, tolerable and free of side effects.
|
CELLULAR THERAPY |
Enhances the body's innate healing capabilities |
|
Targets and diminishes areas of inflammation |
|
Shows Bone marrow-derived MSCs promote prostate cancer growth and metastasis
|
Model depicting putative potential mechanisms underlying primary prostate cancer progression via mescenchymal cell (MSC) recruitment and bone metastasis. Cancer cells secrete CXCL16, which attracts MSCs to tumour sites.
Tumor-derived CXCL16 binds to its receptor, CXCR6, on MSCs, activating signal transduction and causing MSCs to differentiate into cancer-associated fibroblasts (CAFs), which secrete high levels of CXCL12. CXCL12 promotes proliferating cancer cells' malignant transformation to an epithelial-mesenchymal transition (EMT). In prostate cancer cells, EMT increases CXCR4 expression. The expression of CXCR4 promotes metastasis. |
CELL TISSUE TECHNOLOGY SDN BHD
Malaysia's FIRST Tissue Engineering Firm |
|